Diagnostic Impact of Dual-Time PET/CT with <sup>68</sup>Gallium-PSMA in Prostate Cancer and <sup>68</sup>Gallium-DOTATOC in Neuroendocrine Tumors.

Librizzi, Damiano; Eilsberger, Friederike; Ottenthaler, Stefan; Ebrahimifard, Ali; Luster, Markus; Yousefi, Behrooz H

Diagnostic Impact of Dual-Time PET/CT with ⁶⁸Gallium-PSMA in Prostate Cancer and ⁶⁸Gallium-DOTATOC in Neuroendocrine Tumors.

Librizzi, Damiano; Eilsberger, Friederike; Ottenthaler, Stefan; Ebrahimifard, Ali; Luster, Markus; Yousefi, Behrooz H.

Afiliação

Librizzi D; Department of Nuclear Medicine, School of Medicine, Philipps University Marburg, 35043 Marburg, Germany.
Eilsberger F; Department of Nuclear Medicine, School of Medicine, Philipps University Marburg, 35043 Marburg, Germany.
Ottenthaler S; Department of Nuclear Medicine, School of Medicine, Philipps University Marburg, 35043 Marburg, Germany.
Ebrahimifard A; Department of Nuclear Medicine, School of Medicine, Philipps University Marburg, 35043 Marburg, Germany.
Luster M; Department of Nuclear Medicine, School of Medicine, Philipps University Marburg, 35043 Marburg, Germany.
Yousefi BH; Department of Nuclear Medicine, School of Medicine, Philipps University Marburg, 35043 Marburg, Germany.

Biomedicines ; 11(4)2023 Mar 29.

Article em En | MEDLINE | ID: mdl-37189670

Palavras-chave

68gallium; DOTATOC; PET/CT; PSMA; dual-time; neuroendocrine tumor; prostate cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Biomedicines Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google